These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Clinical experience of Hypatal (adrenergic neurone-blocking agent)]. Mori K; Suzuki T; Kashiwagi M; Yokoyama H; Edo S Naika Hokan; 1966 Oct; 13(10):455-9. PubMed ID: 6009580 [No Abstract] [Full Text] [Related]
5. [Studies on the effect of Guanutil in the stationary treatment of arterial hypertension]. Schnabel W Dtsch Gesundheitsw; 1971 Aug; 26(32):1507-11. PubMed ID: 5114582 [No Abstract] [Full Text] [Related]
6. Safety and efficacy of a three-drug regimen for the treatment of hypertension: hydrochlorothiazide, propranolol, and guanadrel. Gore RD Clin Ther; 1983; 6(1):86-93. PubMed ID: 6673832 [TBL] [Abstract][Full Text] [Related]
7. [Guancydine. Clinical evaluation of a new hypotensive agent]. da Silva JA; Antunes NM; Laraia Cde B; Fraga Filho C Rev Bras Med; 1972 Jan; 29(1):42-7. PubMed ID: 5017517 [No Abstract] [Full Text] [Related]
8. Comparison of guanadrel and guanethidine efficacy and side effects. Malinow SH Clin Ther; 1983; 5(3):284-9. PubMed ID: 6850722 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of arterial hypertension with a single daily dose of guanfacine]. Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438 [No Abstract] [Full Text] [Related]
10. Hemodynamic effects of a new antihypertensive agent, guanadrel sulfate. Cangiano JL; Bloomfield DK Curr Ther Res Clin Exp; 1969 Dec; 11(12):736-44. PubMed ID: 4984037 [No Abstract] [Full Text] [Related]
11. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance]. Schäfer N; Knaup G Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756 [No Abstract] [Full Text] [Related]
12. Evaluation of the antihypertensive effect of atenolol in fixed or free combination with chlorthalidone. Nissinen A; Tuomilehto J Pharmatherapeutica; 1980; 2(7):462-8. PubMed ID: 7010382 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the antihypertensive effectiveness of guanadrel and guanethidine. Chrysant SG; Frohlich ED Curr Ther Res Clin Exp; 1976 Mar; 19(3):379-85. PubMed ID: 817868 [No Abstract] [Full Text] [Related]
14. Clinical assessment of the new antihypertensive Compound--1029 (Vatensol)--Guanoclor. Mehta AB; Biswas AK; Pinto IJ; Sheth UK Indian Heart J; 1967 Oct; 19(4):322-8. PubMed ID: 4870898 [No Abstract] [Full Text] [Related]
15. Debrisoquin sulfate: a clinical evaluation of a new antihypertensive agent. Blechman M; Sokol C; Moser M Curr Ther Res Clin Exp; 1969 Feb; 11(2):71-6. PubMed ID: 4975816 [No Abstract] [Full Text] [Related]
16. Further observations on a new antihypertensive Vatensol (Compound 1029). Srivastava BN; Vyas GP; Tiwari AK; Tapa RS; Nema HS Indian Heart J; 1967 Oct; 19(4):329-35. PubMed ID: 4870899 [No Abstract] [Full Text] [Related]
17. Guanadrel (Hylorel)--a new antihypertensive drug. Med Lett Drugs Ther; 1983 Oct; 25(646):95-6. PubMed ID: 6621504 [No Abstract] [Full Text] [Related]
18. [Alpha-blockers in therapy of arterial hypertension. No longer the drug of first choice]. Faulhaber HD MMW Fortschr Med; 2001 May; 143(22):30-2. PubMed ID: 11460395 [No Abstract] [Full Text] [Related]
19. Guanadrel. A new antihypertensive drug. Dunn MI; Dunlap JL JAMA; 1981 Apr; 245(16):1639-42. PubMed ID: 7206175 [TBL] [Abstract][Full Text] [Related]
20. Guanfacine: a new centrally-acting antihypertensive agent. Beevers DG; Bloxham CA; Walker JM Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]